LTRN

Lantern Pharma (LTRN)

About Lantern Pharma (LTRN)

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.

Details

Daily high

$2.15

Daily low

$2.04

Price at open

$2.06

52 Week High

$5.74

52 Week Low

$1.11

Market cap

23.7M

Dividend yield

0.00%

Volume

118,012

Avg. volume

238,576

P/E ratio

-1.34

Lantern Pharma News